Boston Scientific Corp. Files 8-K on Shareholder Votes

Ticker: BSX · Form: 8-K · Filed: 2025-05-06T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, debt-filing

Related Tickers: BSX

TL;DR

BSX filed an 8-K on shareholder votes and debt; nothing major changed.

AI Summary

Boston Scientific Corporation filed an 8-K on May 6, 2025, reporting on matters submitted to a vote of security holders as of May 1, 2025. The filing details the company's common stock and senior notes due in 2027.

Why It Matters

This filing provides transparency on corporate governance matters and financial instruments, which is crucial for investors to understand the company's structure and obligations.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of corporate actions and does not indicate any immediate financial distress or significant new risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of security holders?

The filing indicates that matters were submitted to a vote of security holders as of May 1, 2025, but the specific details of these matters are not elaborated upon in the provided text.

What is the significance of the 'Senior Notes due 2027' mentioned in the filing?

The mention of 'bsx:SeniorNotedue2027Member' indicates that Boston Scientific Corporation has outstanding senior notes with a maturity date in 2027, which are a form of debt financing.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 1, 2025.

What is Boston Scientific Corporation's state of incorporation?

Boston Scientific Corporation is incorporated in Delaware.

What is the primary business address of Boston Scientific Corporation?

The primary business address of Boston Scientific Corporation is 300 Boston Scientific Way, Marlborough, Massachusetts 01752-1234.

From the Filing

0000885725-25-000028.txt : 20250506 0000885725-25-000028.hdr.sgml : 20250506 20250506162609 ACCESSION NUMBER: 0000885725-25-000028 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250501 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20250506 DATE AS OF CHANGE: 20250506 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 25917658 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 8-K 1 bsx-20250501.htm 8-K bsx-20250501 0000885725 false 0000885725 2025-05-01 2025-05-01 0000885725 us-gaap:CommonStockMember 2025-05-01 2025-05-01 0000885725 bsx:SeniorNotedue2027Member 2025-05-01 2025-05-01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________ FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 _____________________________________________________________________ Date of Report (Date of earliest event reported): May 1, 2025 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 1-11083 04-2695240 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)      300 Boston Scientific Way , Marlborough , Massachusetts                  01752-1234     (Address of principal executive offices)                           (Zip Code) ( 508 ) 683-4000 (Registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.01 par value per share BSX New York Stock Exchange 0.625% Senior Notes due 2027 BSX27 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company    ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐ Item 5.07 Submission of Matters to a Vote of Security Holders. (a) Boston Scientific Corporation (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) on May 1, 2025, in a virtual format via live webcast. (b) The final voting results for each matter submitted to stockho

View on Read The Filing